Jonathan Siegal
Comptroller/Controller/Auditor at VERICEL CORPORATION
Net worth: 72 828 $ as of 2024-03-30
Profile
Jonathan D.
Siegal is currently working as the Chief Accounting Officer, VP & Controller at Vericel Corp.
Prior to his current position, he worked as the Global Controller at Lantheus Medical Imaging, Inc. from 2016 to 2021.
Mr. Siegal completed his undergraduate degree at Gordon College.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
VERICEL CORPORATION
0.00% | 2024-03-06 | 1,400 ( 0.00% ) | 72 828 $ | 2024-03-30 |
Jonathan Siegal active positions
Companies | Position | Start |
---|---|---|
VERICEL CORPORATION | Comptroller/Controller/Auditor | - |
Former positions of Jonathan Siegal
Companies | Position | End |
---|---|---|
Lantheus Medical Imaging, Inc.
Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA. | Comptroller/Controller/Auditor | 2020-12-31 |
Training of Jonathan Siegal
Gordon College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
VERICEL CORPORATION | Health Technology |
Private companies | 1 |
---|---|
Lantheus Medical Imaging, Inc.
Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA. | Health Technology |
- Stock Market
- Insiders
- Jonathan Siegal